High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission

Blood

Volumn 88, Issue 7, 1996, Pages 2780-2786

  Freedman, Arnold S ^a   Gribben, John G ^b   Neuberg, Donna ^b   Mauch, Peter ^b   Soiffer, Robert J ^b   Anderson, Kenneth C ^b   Pandite, Lini ^b   Robertson, Michael J ^b   Kroon, Mary ^b   Ritz, Jerome ^b   Nadler, Lee M ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCLONAL ANTIBODY; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 10144243981     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2780.bloodjournal8872780     Document Type: Article

References (38)

1. Horning SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphoma. N Engl J Med 311:1471, 1984
2. Berinstein NL, Jamal HH, Kuzniar B, Klock RJ, Reis MD: Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment. Leukemia 7:113, 1993
3. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
4. Hickish TF, Purvies H, Mansi J, Soukop M, Cunningham D: Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification. Br J Cancer 64:1161, 1991
5. Lambrechts AC, Hupkes PE, Dorssers LCJ, van't Veer MB: Clinical significance of translocation t(14;18) positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 12:1541, 1994
6. Bastion Y, Brice P, Haioun C, Sonet A, Salles G, Marolleau J, Espinouse D, Reyes F, Gisselbrecht C, Coiffier B: Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 86:3257, 1995
7. Haas R, Moos M, Karcher A, Mohle R, Witt B, Goldschmidt H, Fruhauf S, Flentje M, Wannenmacher M, Hunstein W: Sequential high dose therapy with peripheral blood progenitor cell support in low grade non-Hodgkin's lymphoma. J Clin Oncol 12:1685, 1994
8. Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS, Malpas JS, Lister TA: Follicular lymphoma: Prognostic factors for response and survival. J Clin Oncol 4:1470, 1986
9. Schouten HC, Bierman PJ, Vaughan WP, Kessinger A, Vose JM, Weisenburger DD, Armitage JO: Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 74:2579, 1989
10. Freedman AS, Ritz J, Neuberg D, Anderson KC, Rabinowe SN, Mauch P, Takvorian T, Soiffer R, Blake K, Yeap B, Coral F, Helfin L, Nadler LM: Autologous bone marrow transplantation in 69 patients with a history of low grade B cell non-Hodgkin's lymphoma. Blood 77:2524, 1991
11. Vose J, Bierman P, Armitage J: High dose chemotherapy with stem cell rescue for the treatment of follicular low grade non-Hodgkin's lymphoma. Autologous Bone Marrow Transplantation. Omaha, NE, Proceedings of the Fifth International Symposium V:479, 1991
12. Rohatiner A, Johnson P, Price C Arnott, SJ, Amess J, Norton A, Dorey E, Adams K, Whelan J, Matthews J, MacCallum P, Oza A, Lister T: Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 12:1177, 1994
13. Colombat P, Donadio D, Fouillard L, Milpied N, Tilly H, Pico J, Abrgrall J, Coiffier B, Herbrecht R, Philip T: Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 13:157, 1994
14. Thomas ED, Clift RA: Indications for marrow transplantation in chronic myelogenous leukemia. Blood 73:861, 1989
15. Freedman AS, Takvorian T, Anderson KC, Mauch P, Rabinowe SN, Blake K, Yeap B, Soiffer R, Coral F, Heflin L, Ritz J, Nadler LM: Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: Very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 8:1, 1990
16. Gribben J, Neuberg D, Barber M, Moore J, Pesek K, Freedman A, Nadler L: Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994
17. Kaplan E, Meier O: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
18. Mantel N: Evaluation of statistical data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
19. Gribben J, Freedman A, Woo S, Blake K, Shu R, Freeman G, Longtine J, Pinkus G, Nadler L: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991
20. Johnson P, Rohatiner A, Whelan J, Price C, Love S, Lim J, Mattews J, Norton A, Amess J, Lister T: Patterns of survival in patients with recurrent follicular lymphoma: a 20 year study from single center. J Clin Oncol 13:140, 1995
21. Gribben J, Neuberg D, Freedman A, Gimmi C, Pesek K, Barber M, Saporito L, Woo S, Coral F, Spector N, Rabinowe S, Grossbard M, Ritz J, Nadler L: Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81:3449, 1993
22. Price CGA, Meerabux J, Murtagh S, Cotter FE, Rohatiner AZS, Young BD, Lister TA: The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 9:1527, 1991
23. Lambrechts A, Hupkes P, Dorssers L, Van't Veer M: Translocation (14;18) positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood 82:2510, 1993
24. Finke J, Slanina J, Lange W, Dolken G: Persistence of circulating t(14;18)-positive cells in long term remission after radiation therapy for localized stage follicular lymphoma. J Clin Oncol 11:1668, 1993
25. Miller J, Arthur D, Litz C, Neglia J, Miller W, Weisdorf D: Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy. Blood 83:3780, 1994
26. Stone R, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe S, Aster J, Leavitt P, Mauch P, Freedman A, Nadler L: Myelodysplastic syndrome as a late complication following autologous transplantation for non-Hodgkin's lymphoma. J Clin Oncol 12:2534, 1994
27. Traweek S, Slovak M, Nademanee A, Brynes R, Niland J, Forman S: Clonal karyotypic hematopoietic cell abnormalities occuring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 84:857, 1994
28. Vose J, Darrington D, Bierman P, Bishop M, Anderson J, Kessinger A, Armitage J: Myelodysplastic syndrome/acute myelogenous leukemia following high dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: Characterization and relative risk. Lugano, Switzerland, Proceedings of the Fifth International Conference on Malignant Lymphoma, 1993, p 42
29. Stone R: Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress? Blood 83:3437, 1994
30. Bastion Y, Coiffier B: Is the International Prognostic Index for aggressive lymphoma patients useful follicular lymphoma patients. J Clin Oncol 12:1340, 1994
31. Lopez-Guillermo A, Montserrat E, Bosch F, Terol M, Campo E, Rozman C: Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 12:1343, 1994
32. Romaguera J: Can we identify patients with low grade lymphoma for frontline ABMT. Leuk Lymphoma 10:9, 1993 (suppl)
33. Dana B, Dahlberg S, Nathwani B, Chase E, Coltman C, Miller T, Fisher R: Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. J Clin Oncol 11:644, 1993
34. Gribben J, Saporito L, Barber M, Blake K, Edwards R, Griffin J, Freedman A, Nadler L: Bone marrow of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood 80:1083, 1992
35. Grossbard M, Press O, Appelbaum F, Bernstein I, Nadler L: Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 80:863, 1992
36. Klingemann H, Grigg A, Wilkie-Boyd K, Barnett M, Eaves A, Reece D, Shepard J, Phillips G: Treatment with recombinant Interferon (α-2b) early after bone marrow transplantation in patients at high risk for relapse. Blood 78:3306, 1991
37. Vey N, Blaise D, Tiberghein P, Attal M, Pico J, Reiffers J, Harrousseau J, Fiere D, Tabilio A, Gabus R, Brandely M, Maraninchi D: A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas. Leuk Lymphoma 21:107, 1996
38. Kwak L, Campbell M, Czerwinski D, Hart S, Miller R, Levy R: Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327:1209, 1992